Your browser doesn't support javascript.
loading
Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In Humans.
Itkonen, Matti K; Tornio, Aleksi; Neuvonen, Mikko; Neuvonen, Pertti J; Niemi, Mikko; Backman, Janne T.
Afiliación
  • Itkonen MK; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Tornio A; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland aleksi.tornio@helsinki.fi.
  • Neuvonen M; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Neuvonen PJ; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Niemi M; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Backman JT; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Drug Metab Dispos ; 47(4): 377-385, 2019 04.
Article en En | MEDLINE | ID: mdl-30630815
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Gemfibrozilo / Loratadina / Citocromo P-450 CYP2C8 / Inhibidores del Citocromo P-450 CYP2C8 / Clopidogrel Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Drug Metab Dispos Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Gemfibrozilo / Loratadina / Citocromo P-450 CYP2C8 / Inhibidores del Citocromo P-450 CYP2C8 / Clopidogrel Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Drug Metab Dispos Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Finlandia